The peptide also stimulates oxytocin release from hypothalamic neurons, contributing to its effects on social behavior and bonding
While Novo got a head start in the GLP-1 market with its earlier approvals, analysts predict that Zepbounds superior efficacy and tolerability will drive significant market share gains for Lilly, potentially surpassing Wegovy in global sales
Some appetite changes, sleeping a bit deeper, nothing dramatic
U54HD061221), which is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and NIH K08DK106453
That demand led some pharmacists to a creative interpretation of the existing compounding exemptions, allowing them to make their own version of drugs that aren't commercially available